SCHEMBL7346565

SCHEMBL7346565

COC(=O)C(CCC=S)NC(c1ccccc1)S(=O)(=O)c1ccc(OC)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 10/20 0.47
PDE4B Q07343 10/20 0.47
PDE4C Q08493 10/20 0.47
PDE4D Q08499 10/20 0.47
MMP2 P08253 8/20 0.47
MMP3 P08254 8/20 0.47
MMP13 P45452 4/20 0.46
MMP1 P03956 10/20 0.45
MMP9 P14780 2/20 0.43
KLK7 P49862 1/20 0.42
NPC1 O15118 2/20 0.41
ALDH1A1 P00352 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
KDM4E B2RXH2 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7340578 0.78 MMP2 (0.49) MMP2MMP3MMP13MMP1MMP9
SCHEMBL7371953 0.69 MMP2 (0.56) PDE4APDE4BPDE4CPDE4DMMP2
SCHEMBL7364753 0.68 ALDH1A1 (0.49) PDE4APDE4BPDE4CPDE4DMMP2
SCHEMBL7207785 0.66 PDE4A (0.77) PDE4APDE4BPDE4CPDE4DMMP2
SCHEMBL4796904 0.66 ALDH1A1 (0.49) PDE4APDE4BPDE4CPDE4DMMP2
SCHEMBL7207560 0.66 MMP13 (0.75) PDE4APDE4BPDE4CPDE4DMMP2
SCHEMBL7380941 0.65 SLC1A3 (0.54) PDE4APDE4BPDE4CPDE4DMMP2
SCHEMBL7208714 0.65 MMP1 (0.48) PDE4APDE4BPDE4CPDE4DMMP2
SCHEMBL29540673 0.65 MMP2 (0.73) MMP2MMP3MMP13MMP1MMP9
SCHEMBL6323452 0.65 MMP2 (0.73) MMP2MMP3MMP13MMP1MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0606046-B1 Arylsulfonamido-substituted hydroxamic acids CIBA GEIGY AG (CH) 1997-10-08 EP disclosed
US-5646167-A ADMINISTERED AS METALLOPROTEINASE INHIBITOR, ANTITUMOR OR ANTICARCINOGENIC AGENT CIBA-GEIGY CORPORATION (US) 1997-07-08 US disclosed
US-5552419-A METALLOPROTEINASE INHIBITORS CIBA-GEIGY CORPORATION (US) 1996-09-03 US disclosed
US-5506242-A METALLOELASTASE INHIBITOR; TREATS EMPHYSEMA CIBA-GEIGY CORPORATION (US) 1996-04-09 US disclosed
US-5455258-A Useful as inhibitors of matrix-degrading metalloproteinase enzymes such as stromelysin and/or collegenase CIBA-GEIGY CORPORATION (US) 1995-10-03 US disclosed
EP-0606046-A1 Arylsulfonamido-substituted hydroxamic acids CIBA-GEIGY AG (CH) 1994-07-13 EP disclosed